BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1628 related articles for article (PubMed ID: 26713745)

  • 1. The role of microglia and macrophages in glioma maintenance and progression.
    Hambardzumyan D; Gutmann DH; Kettenmann H
    Nat Neurosci; 2016 Jan; 19(1):20-7. PubMed ID: 26713745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats.
    Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H
    Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.
    Zhu C; Mustafa D; Zheng PP; van der Weiden M; Sacchetti A; Brandt M; Chrifi I; Tempel D; Leenen PJM; Duncker DJ; Cheng C; Kros JM
    Neuro Oncol; 2017 May; 19(5):648-659. PubMed ID: 28453746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia and central nervous system immunity.
    Kaur G; Han SJ; Yang I; Crane C
    Neurosurg Clin N Am; 2010 Jan; 21(1):43-51. PubMed ID: 19944965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
    Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 ligand deficiency accelerates glioma progression by promoting the formation of tumor immune microenvironment.
    Duan J; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
    Int Immunopharmacol; 2019 Jun; 71():350-360. PubMed ID: 30952099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
    Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
    Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The controversial role of microglia in malignant gliomas.
    Wei J; Gabrusiewicz K; Heimberger A
    Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions between tumor and its microenvironment in malignant gliomas.
    Ellert-Miklaszewska A; Pasierbinska M; Poleszak K; Kamińska B
    Postepy Biochem; 2018 Oct; 64(2):129-140. PubMed ID: 30656895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Benedict Arnold of the Central Nervous System Tumor Microenvironment? The Role of Microglia/Macrophages in Glioma.
    Bander ED; Rivera M; Cisse B
    World Neurosurg; 2021 Oct; 154():214-221. PubMed ID: 34583498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
    Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
    Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.
    Ye XZ; Xu SL; Xin YH; Yu SC; Ping YF; Chen L; Xiao HL; Wang B; Yi L; Wang QL; Jiang XF; Yang L; Zhang P; Qian C; Cui YH; Zhang X; Bian XW
    J Immunol; 2012 Jul; 189(1):444-53. PubMed ID: 22664874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
    Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
    Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microglia and P2X7 receptors in gliomas.
    Kan LK; Williams D; Drummond K; O'Brien T; Monif M
    J Neuroimmunol; 2019 Jul; 332():138-146. PubMed ID: 31031209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immunosuppressive microenvironment of malignant gliomas].
    Borisov KE; Sakaeva DD
    Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology.
    Gutmann DH; Kettenmann H
    Neuron; 2019 Nov; 104(3):442-449. PubMed ID: 31697921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
    Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
    Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.